Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
12,327,157
-
Shares change
-
-765,963
-
Total reported value, excl. options
-
$86,290,610
-
Value change
-
-$5,570,945
-
Number of buys
-
24
-
Number of sells
-
-21
-
Price
-
$7
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2017
59 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q4 2017.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,327,157 shares
of 76,991,404 outstanding shares and own 16.01% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (2,797,758 shares), Cormorant Asset Management, LLC (1,940,880 shares), BlackRock Inc. (983,125 shares), Hillhouse Capital Management, Ltd. (944,202 shares), Rock Springs Capital Management LP (935,000 shares), Vanguard Group Inc (772,215 shares), PERCEPTIVE ADVISORS LLC (620,181 shares), FMR LLC (534,447 shares), SPHERA FUNDS MANAGEMENT LTD. (450,000 shares), and FIRST MANHATTAN CO (350,000 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.